Tillman U. Gerngross - Net Worth and Insider Trading

Tillman U. Gerngross Net Worth

The estimated net worth of Tillman U. Gerngross is at least $232,589 dollars as of 2024-11-13. Tillman U. Gerngross is the Director of X4 Pharmaceuticals Inc and owns about 392,821 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $232,589. Details can be seen in Tillman U. Gerngross's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tillman U. Gerngross has not made any transactions after 2017-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tillman U. Gerngross

To

Tillman U. Gerngross Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tillman U. Gerngross owns 3 companies in total, including Alector Inc (ALEC) , X4 Pharmaceuticals Inc (XFOR) , and Invivyd Inc (IVVD) .

Click here to see the complete history of Tillman U. Gerngross’s form 4 insider trades.

Insider Ownership Summary of Tillman U. Gerngross

Ticker Comapny Transaction Date Type of Owner
ALEC Alector Inc 2023-06-14 director
XFOR X4 Pharmaceuticals Inc 2017-11-20 director & 10 percent owner
IVVD Invivyd Inc 2021-08-05 director & 10 percent owner & Chief Executive Officer

Tillman U. Gerngross Latest Holdings Summary

Tillman U. Gerngross currently owns a total of 1 stock. Tillman U. Gerngross owns 392,821 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $232,589.

Latest Holdings of Tillman U. Gerngross

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2017-11-20 392,821 0.59 232,589

Holding Weightings of Tillman U. Gerngross


Tillman U. Gerngross Form 4 Trading Tracker

According to the SEC Form 4 filings, Tillman U. Gerngross has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 200,000 shares on November 20, 2017, which cost Tillman U. Gerngross around $2 Million.

Insider Trading History of Tillman U. Gerngross

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tillman U. Gerngross Trading Performance

GuruFocus tracks the stock performance after each of Tillman U. Gerngross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tillman U. Gerngross is 0.28%. GuruFocus also compares Tillman U. Gerngross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tillman U. Gerngross within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tillman U. Gerngross's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tillman U. Gerngross

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.73 LIMIT LIMIT LIMIT LIMIT LIMIT

Tillman U. Gerngross Ownership Network

Ownership Network List of Tillman U. Gerngross

No Data

Ownership Network Relation of Tillman U. Gerngross

Insider Network Chart

Tillman U. Gerngross Owned Company Details

What does Alector Inc do?

Who are the key executives at Alector Inc?

Tillman U. Gerngross is the director of Alector Inc. Other key executives at Alector Inc include President and Head of R&D Sara Kenkare-mitra , Chief Medical Officer Gary Romano , and director & Chief Executive Officer Arnon Rosenthal .

Alector Inc (ALEC) Insider Trades Summary

Over the past 18 months, Tillman U. Gerngross made no insider transaction in Alector Inc (ALEC). Other recent insider transactions involving Alector Inc (ALEC) include a net sale of 105,204 shares made by Arnon Rosenthal , a net sale of 60,126 shares made by Sara Kenkare-mitra , and a net sale of 32,942 shares made by Gary Romano .

In summary, during the past 3 months, insiders sold 100,450 shares of Alector Inc (ALEC) in total and bought 0 shares, with a net sale of 100,450 shares. During the past 18 months, 1,284,693 shares of Alector Inc (ALEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,284,693 shares.

Alector Inc (ALEC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alector Inc Insider Transactions

No Available Data

Tillman U. Gerngross Mailing Address

Above is the net worth, insider trading, and ownership report for Tillman U. Gerngross. You might contact Tillman U. Gerngross via mailing address: C/o Arsanis, Inc., 890 Winter Street, Suite 230, Waltham Ma 02451.